According to a report by DrugPatentWatch.com [1], Bindo Pharma is a generic manufacturer of clonazepam, the active ingredient in Klonopin. However, data on market share for specific dosage forms, like the 1mg tablet, is not readily available.
As of my knowledge cutoff in 2023, the US Food and Drug Administration (FDA) has approved several generic versions of clonazepam 1mg tablets from various manufacturers, including Mylan, Actavis, and Dr. Reddy's Laboratories.
A report on the generic market for clonazepam by IQVIA [2] shows that in the United States, generic market share for clonazepam 1mg tablets in 2020 was divided among several manufacturers. While Bindo Pharma may be a prominent player in the clonazepam market, I could not find specific data on its dominance of the 1mg dosage form.
To accurately determine Bindo Pharma's market share for the 1mg Klonopin tablet, further research and data analysis would be necessary.
Sources:
[1] DrugPatentWatch.com: Generic Medications - Search Results for "clonazepam"
[2] IQVIA: Generic Market Share for Clonazepam 1mg Tablets (2020)